Cytocom
Fort Collins
About Cytocom
Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most promising approaches in the treatment of Cancers, HIV, Autoimmune Diseases, inflammatory conditions and other chronic infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $94.3M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2021)
- Ticker: nasdaq:CBLI
- Website: cytocom.com
- Phone: 1-888-629-4155
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/cytocom-59016 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.